Morphogenesis of recombinant HIV-2 gag core particles.
The gag-pol coding region of the HIV-2BEN genome was expressed in CV-1 cells infected with four recombinant vaccinia viruses (VV). These recombinant VV encoded either the whole gag-pol region or the gag gene including the protease-coding region of the pol gene or the gag gene truncated at its 3'-end or only the pol gene. The HIV-2BEN gag precursor p55, its mature cleavage products p24 and p17 as well as the pol reverse transcriptase (RT) p66 were detected in VV-infected CV-1 cells. The p55 and two intermediate cleavage products p40 and p35 were myristilated. Comparison to lysates of permanently HIV-2BEN-infected Molt 4 clone 8 cells revealed that several additional gag and pol proteins were present in the VV-infected CV-1 cells. Deletion of the gag and pol overlapping region coding for the viral protease prevented cleavage of the recombinant gag precursor. Electron microscopy of VV-infected CV-1 cells revealed budding structures and immature as well as mature retroviral particles formed by the recombinant gag proteins. Striking differences in the ability to form complete particles were observed between the different recombinant VV. Expression of the truncated gag gene led to the formation of budding structures, but completely budded circular particles were not detectable. Such particles were produced by expression of the whole gag gene and the protease. Mature virions with an internal core structure were only detected in VVgagpol-infected cells. From these findings we conclude that the 3'-end of the gag gene coding for the p16 protein is essential for the formation of complete HIV-2 particles and that the pol proteins support the assembly of the viral core.
Voss
G
G
Deutsches Primatenzentrum, Abteilung Virologie und Immunologie, Göttingen, Germany.
Kirchhoff
F
F
Nick
S
S
Moosmayer
D
D
Gelderblom
H
H
Hunsmann
G
G
D001483:Base Sequence; D004274:DNA, Recombinant / Q000096:biosynthesis / Q000235:genetics; D015683:Gene Products, gag / Q000096:biosynthesis* / Q000235:genetics / Q000648:ultrastructure; D015684:Gene Products, pol / Q000096:biosynthesis* / Q000235:genetics / Q000648:ultrastructure; D015750:Genes, gag / Q000502:physiology; D015751:Genes, pol / Q000502:physiology; D016333:HIV Protease / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D015498:HIV-2 / Q000737:chemistry / Q000235:genetics* / Q000648:ultrastructure; D008969:Molecular Sequence Data; D011498:Protein Precursors / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology; D011499:Protein Processing, Post-Translational
D004274:DNA, Recombinant; D015683:Gene Products, gag; D015684:Gene Products, pol; D011498:Protein Precursors; D016333:HIV Protease